Us Bancorp \De\ Assembly Biosciences, Inc. Transaction History

Us Bancorp \De\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 28, 2021	SELL	$4.33 - $6.63 $679 - $1,040	-157 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$14.57 - $23.96 $2,287 - $3,761	157 New	157 $4,000
Q4 2018 Feb 13, 2019	SELL	$19.05 - $36.45 $3,810 - $7,290	-200 Closed	0 $0
Q3 2018 Nov 01, 2018	BUY	$34.41 - $44.23 $6,881 - $8,846	200 New	200 $7,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $647M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.